VNDA
Vanda Pharmaceuticals Inc
NASDAQ · Biotechnology
$7.57
+0.34 (+4.70%)
Open$7.37
Previous Close$7.23
Day High$7.72
Day Low$7.30
52W High$9.60
52W Low$3.81
Volume—
Avg Volume950.6K
Market Cap468.81M
P/E Ratio—
EPS$-1.43
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+104.1% upside
Current
$7.57
$7.57
Target
$15.45
$15.45
$11.33
$15.45 avg
$18.37
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 211.70M | 234.07M | 134.97M |
| Net Income | -20,127,370 | -20,029,448 | 17.72M |
| Profit Margin | -9.5% | -9.0% | 13.1% |
| EBITDA | -16,665,462 | -17,505,737 | 23.46M |
| Free Cash Flow | — | — | 19.80M |
| Rev Growth | -9.6% | -9.6% | -3.5% |
| Debt/Equity | 0.01 | 0.01 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |